[ad_1] Theranos founder and former chief executive Elizabeth Holmes was sentenced to 135 months, or over 11 years, in prison, putting an endpoint on the unraveling...
[ad_1] By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients with relapsed or refractory multiple myeloma didn’t meet its primary...
[ad_1] First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a “substantially higher”...
[ad_1] The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from the previous week, while the death toll fell 5%, the...
[ad_1] Investors cheered when a report last week showed the economy expanded in the third quarter after back-to-back contractions. But it’s too early to get excited,...
[ad_1] President Joe Biden will receive his updated COVID booster on Tuesday and will urge Americans to get the shot, which targets both the original virus...
[ad_1] Pfizer Inc. PFE, +4.17% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +7.14% for $110 to $130...
[ad_1] You probably already know that because of market-capitalization weighting, a broad index such as the S&P 500 SPX, -0.67% can be concentrated in a handful...
[ad_1] Moderna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck...
[ad_1] Royal Philips NV said Wednesday that its performance for the third quarter was hurt by stronger-than-anticipated supply-chain challenges, and adopted a more pessimistic view on...
[ad_1] Bio-Rad Laboratories is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according...
[ad_1] When the stock market has jumped two days in a row, as it has now, it is easy to become complacent. But the Federal Reserve...